| Style | Citing Format |
|---|---|
| MLA | Afra F, et al.. "Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?." Current Journal of Neurology, vol. 24, no. 3, 2025, pp. 251-253. |
| APA | Afra F, Shaban E, Mojtahedzadeh A, Mojtahedzadeh M (2025). Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?. Current Journal of Neurology, 24(3), 251-253. |
| Chicago | Afra F, Shaban E, Mojtahedzadeh A, Mojtahedzadeh M. "Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?." Current Journal of Neurology 24, no. 3 (2025): 251-253. |
| Harvard | Afra F et al. (2025) 'Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?', Current Journal of Neurology, 24(3), pp. 251-253. |
| Vancouver | Afra F, Shaban E, Mojtahedzadeh A, Mojtahedzadeh M. Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?. Current Journal of Neurology. 2025;24(3):251-253. |
| BibTex | @article{ author = {Afra F and Shaban E and Mojtahedzadeh A and Mojtahedzadeh M}, title = {Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing?}, journal = {Current Journal of Neurology}, volume = {24}, number = {3}, pages = {251-253}, year = {2025} } |
| RIS | TY - JOUR AU - Afra F AU - Shaban E AU - Mojtahedzadeh A AU - Mojtahedzadeh M TI - Reconsidering Milrinone: Time to Revive the Oral Form for Drug Repurposing? JO - Current Journal of Neurology VL - 24 IS - 3 SP - 251 EP - 253 PY - 2025 ER - |